References
- Laragh J H, Buehler F R, Chobanian A, Hansson L, Zachariah P. Update on calcium antagonists in hypertension. J Cardiovasc Pharmacol 1987; 9(Suppl 4)S1–S3
- Moser M. Calcium entry blockers for systemic hypertension. Am J Cardiol 1987; 59: 115A–121A
- Zanchetti A. Role of calcium antagonists in systemic hypertension. Am J Cardiol 1987; 59: 130B–136B
- Buehler E R, Frohlich E D, Distler A, Macgregor G A, Triggle D J, Zanchetti A. Where do calcium antagonists fit in today's antihypertensive care. J Cardiovasc Pharmacol 1988; 12(Suppl 4)vii–x
- Murphy R A, Gerthoffer W T. Cell calcium and contractile system regulation in arterial smooth muscle. Calcium antagonists and cardiovascular disease, L H Opie. Raven Press, New York 1984; 75–85
- Van Houtte P M. Calcium-entry blockers, vascular smooth muscle and systemic hypertension. Am J Cardiol 1985; 55: 178–238
- Goa K L, Sorkin E M. Nitrendipine a review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in the treatment of hypertension. Drugs 1987; 33: 123–155
- Hansson L, Andren L, Oroe L, Ryman T. The antihypertensive effects of nitrendipine in patients with essential hypertension. Nitrendipine, A Scriabine. Urban and Scwharzenberg, Baltimore 1984; 423–433
- Hulten U L, Katzman P L. Review of long-term trials with nitrendipine. J Cardiovasc Pharmacol 1988; 12(Suppl 4)11–15
- Muller F B, Bolli P, Erne P, Block L H, Kiowski W, Buehler F H. Antihypertensive therapy with the long-acting calcium-antagonist nitrendipine. J Cardiovasc Pharmacol 1984; 6(Suppl 7)S1073–1076
- McDonald M, Grimm R H. Compliance with hypertension treatment: strategies for improving patient cooperation. Postgrad Med 1985; 77: 233–242
- Taylor S H, Frais M A, Lee P, Verma S P, Jackson N, Reynolds G, Silke B. A study of the long-term efficacy and tollerability of oral nicardipine in hypertensive patients. Br J Clin Pharmacol 1985; 20: 139S–142S
- Agree K. An overview of the safety and efficacy of nicardipine in clinical trials. Am J Cardiol 1987; 59: 31J–35J
- Castle C H, Wolbach R A. Long-term systemic arterial blood pressure control with nicardipine. Am J Cardiol 1989; 64: 35H–41H
- Cost J P, O'Brien E, O'Malley K. The effect of slow release nicardipine on ambulatory and clinical blood pressure in mild hypertension. Br J Clin Pharmacol 1989; 28: 79–82
- Salvetti A, Cardellino G, Pesenti M, Caiazza A, Ghisoni F, Del Prato C, Innocenti P F, Ponzanelli Errico M, Freda M, Borgnino C. Antihypertensive effect of slow-release nicardipine. Eur J Clin Pharmacol 1989; 36: 439–442
- Casadei R, Parati G, Pomidossi G, Groppelli A, Trazzi S, di Rienzo M, Mancia G. 24 hour blood pressure monitoring: evaluation of Spacelabs 5300 monitor by comparison with intra-arterial blood pressure recording in ambulant subjects. J Hypertens 1988; 6: 797–803
- Dupont A G, Van Der Niepen P, Six R O. Placebo does not lower ambulatory blood pressure. Br J Clin Pharmacol 1987; 24: 106–109
- Rueddel H, Schmieder R, Langewitz W, Neus J, Wagner O. Efficacy of nitrendipine as baseline antihypertensive therapy. J Cardiovasc Pharmacol 1984; 6(Suppl 7)1049–1052
- Moser M, Lunn J, Nash D T, Burris J R, Winern N. Nitrendipine in the treatment of mild to moderate hypertension. J Cardiovasc Pharmacol 1984; 6(Suppl 7)1085–1089
- Mazzola C, Borgnino C, Colombo D, Lissoni F, Serra G, Turri D R, Valsecchi M A. Anthihypertensive and hemodynamic effecdts of slow-release nicardipine. Int J Clin Pharmacol Ther Tox 1988; 26(10)503–508
- Lazarus J H, Littley M D, Philips D IW. Efficacy of once daily nitrendipine in essential hypertension: a study using ambulatory blood pressure monitoring. J Hum Hypertens 1988; 2: 191–194
- Meyer-Sabellek W, Schulte K L, Stremberg B, Gotzen R, Distler A. 24-hour non invasive blood pressure monitoring: evaluation of the anthypertensive circadian profile of nitrendipine. J Cardiovasc Pharmacol 1988; 12(Suppl 4)22–28
- di Rienzo M, Grassi G, Pedotti A, Mancia G. Continuos vs intermittent blood pressure measurements in estimating 24h average blood pressure. Hypertension 1983; 5: 264–269